Literature DB >> 15825398

Enhanced toxicity for mice of 6-mercaptopurine with bacterial endotoxin.

N M Marecki, S G Bradley.   

Abstract

The toxicity of 6-mercaptopurine was potentiated by 2 mg of either Escherichia coli 026:B6 B endotoxin or Salmonella typhosa 0901 W endotoxin per kg. Nonlethal doses of heat-killed, gram-negative bacteria were also capable of potentiating the lethality of 6-mercaptopurine (6-MP). Salmonella minnesota S, the wild-type strain, and S. minnesota Re 595, a mutant containing only the lipid A and 2-keto-3-deoxyoctonate moiety of the endotoxin molecule, exhibited the same capability to enhance the toxic action of 6-MP. Endotoxin (lipopolysaccharide [LPS]) did not affect the clearance of 6-MP from the circulation, but did alter its apparent metabolism as indicated by blood levels of a metabolite, 6-thiouric acid. The concentration of blood urea nitrogen (BUN) in mice 18 h after injection of 100 mg of 6-MP per kg simultaneously with 2 mg of LPS per kg was significantly elevated over normal values. However, these BUN values were significantly less than those resulting from the administration of one mean lethal dose of either agent. The clearance from the circulation of the gram-negative organism E. coli HB, or the gram-positive organism Staphylococcus epidermidis S, was not affected by 6-MP. Endotoxin had no effect on the clearance of S. epidermidis S, but inhibited that of E. coli HB. When 6-MP and LPS were administered simultaneously with either bacterial species, only the clearance of E. coli HB was inhibited. Mice were protected from the lethality associated with combinations of 6-MP and LPS by (i) prior treatment with phenobarbital, (ii) caffeine, (iii) methylprednisolone, and (iv) polymyxin B sulfate. With the exception of caffeine, each regimen protected mice against the lethal effects of 400 mg of 6-MP per kg, and methylprednisolone or polymyxin B protected mice against 8 mg of LPS per kg.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15825398      PMCID: PMC428985          DOI: 10.1128/AAC.5.4.413

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  The toxic effects of 6-mercaptopurine and related compounds.

Authors:  F S PHILIPS; S S STERNBERG; S HAMILTON; D A CLARKE
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

2.  Biological activities of lipid A complexed with bovine-serum albumin.

Authors:  C Galanos; E T Rietschel; O Lüderitz; O Westphal; Y B Kim; D W Watson
Journal:  Eur J Biochem       Date:  1972-12-04

3.  Mitogenicity of bacterial endotoxins: characterization of the mitogenic principle.

Authors:  D L Peavy; J W Shands; W H Adler; R T Smith
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

Review 4.  Infectious complications of neoplastic disease.

Authors:  D Armstrong; L S Young; R D Meyer; A H Blevins
Journal:  Med Clin North Am       Date:  1971-05       Impact factor: 5.456

5.  Enhanced toxicity for mice of pactamycin with bacterial endotoxin.

Authors:  S G Bradley; W C Rose
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

6.  Endotoxin-induced inhibition of renal function in the mouse.

Authors:  H M Bates; S Margolin
Journal:  Proc Soc Exp Biol Med       Date:  1968-11

7.  Rapid determination of urea nitrogen in serum or plasma without deproteinization.

Authors:  C L Crocker
Journal:  Am J Med Technol       Date:  1967 Sep-Oct

8.  Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravascular coagulation and leukopenia.

Authors:  J J Corrigan; B M Bell
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

9.  Enhanced toxicity for mice of combinations of antibiotics with Escherichia coli cells or Salmonella typhosa endotoxin.

Authors:  W C Rose; S G Bradley
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

10.  Enhanced toxicity for mice of combinations of bacterial endotoxin with antitumor drugs.

Authors:  N M Marecki; S G Bradley
Journal:  Antimicrob Agents Chemother       Date:  1973-05       Impact factor: 5.191

View more
  3 in total

1.  Enhanced toxicity for mice of combinations of bacterial lipopolysaccharide and vincristine.

Authors:  A E Munson; D C Drummond; A C Adams; S G Bradley
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

2.  Effects of hepatic function on vancomycin clinical pharmacology.

Authors:  N Brown; D H Ho; K L Fong; L Bogerd; A Maksymiuk; R Bolivar; V Fainstein; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

3.  Effects of endotoxin on the pharmacology of antineoplastic agents.

Authors:  K Lu; M G Rosenblum; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.